<?xml version="1.0"?>
  <rss version="2.0">
    <channel>
      <title>Zidovudine Capsule News : GoldBamboo.com</title>
      <link>http://goldbamboo.com/</link>
      <description>Zidovudine Capsule News from GoldBamboo.com</description>
      <language>en-us</language>
      <copyright>&amp;copy; 2005, Gold Bamboo LLC, All Rights Reserved</copyright>
      
	<item>
        <title>FDA Approves Alpharma's KADIAN(R) New 200 Mg Strength</title>
        <link>http://goldbamboo.com/news-a223523.html</link>
        <description>Alpharma Inc. (NYSE: ALO), a global specialty pharmaceutical company, today announced that it has been notified by United States Food and Drug Administration("FDA") that its pending application for KADIAN(R) 200mg capsule has received approval. The company expects to launch this new dosage strength in the second quarter of 2007. [click link for full article]</description>
		 <pubDate>Fri, 02 Mar 2007 08:00 EST</pubDate>
	</item>
	<item>
        <title>Roche Files Application In Europe For Tamiflu 30 And 45 Mg Capsules</title>
        <link>http://goldbamboo.com/news-a221313.html</link>
        <description>Roche has filed an application with regulatory authorities in Europe requesting an extension of the current Tamiflu license to include smaller capsules of 30 mg and 45 mg in addition to the 75 mg capsule already registered. These lower dosage strengths have been developed mainly for use in children for seasonal and pandemic influenza, as an alternative to the suspension formulation. [click link for full article]</description>
		 <pubDate>Sun, 18 Feb 2007 08:00 EST</pubDate>
	</item>
	<item>
        <title>A New Generation Of Medicinal Products</title>
        <link>http://goldbamboo.com/news-a216524.html</link>
        <description>What is a medicinal product? It is always the result of a subtle marriage between a compound (the active substance which treats a patient) and an appropriate excipient (a neutral substance in which the active substance is incorporated so that it can be absorbed by the body). Thus the necessary tablet, capsule or syrup is obtained. [click link for full article]</description>
		 <pubDate>Sat, 20 Jan 2007 11:00 EST</pubDate>
	</item>
	<item>
        <title>Bristol-Myers Squibb Receives FDA Approval For New Formulation Of Antiretroviral Reyataz</title>
        <link>http://goldbamboo.com/news-a204052.html</link>
        <description>Bristol-Myers Squibb on Friday announced that it has received FDA approval for a single 300 mg capsule formulation of its protease inhibitor Reyataz to be taken as part of combination therapy, Reuters reports. The new formulation is taken once daily and likely will be available within one week, according to BMS (Reuters, 10/20). [click link for full article]</description>
		 <pubDate>Thu, 26 Oct 2006 11:00 EST</pubDate>
	</item>
	<item>
        <title>Bristol wins U.S. approval for single anti-HIV pill</title>
        <link>http://goldbamboo.com/news-a203475.html</link>
        <description>NEW YORK (Reuters) - Bristol-Myers Squibb Co. said on Friday that U.S. regulators approved a single-capsule form of its Reyataz HIV drug to be taken as part of combination drug therapy.</description>
		 <pubDate>Fri, 20 Oct 2006 06:45 EST</pubDate>
	</item>
	

    </channel>
  </rss>
